ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Emerging Scientists Awarded Hopper-Belmont Foundation Grants to Fund Critical Pancreatic and Ovarian Cancer Research

By: PR Leap
(PRLeap.com) The Hopper-Belmont Foundation (HBF) is honoring five of the nation's most innovative early-career cancer researchers with the HBF Inspiration Award.

Since the Foundation's inception in 2020, 21 grantees have received critical funding to propel their research forward. This year's awards focused on two of the deadliest cancers - pancreatic and ovarian. Pancreatic cancer is the third leading cause of cancer death with a five-year survival rate of just 11 percent.

The 2024 awardees are:
  • Ryne Ramaker, MD/PhD, Duke University

  • Nikita Bhalerao, PhD, University of Massachusetts Chan Medical School

  • Jurgis Alvikas, MD, University of Pittsburgh Medical Center

  • Cassandra Holbert, PhD, Johns Hopkins /Loyola University, Maryland

  • Hanna Hong, PhD, Koch Institute at MIT


  • "We are truly excited to present the HBF Inspiration Awards to this talented and dedicated group of researchers," said Joan Fowler, HBF executive director. "Garnering funding for early-career research can be a challenge, and we hope these grants will help these passionate awardees continue their quest for improved treatment outcome and a cure."

    Past award recipients have gone on to win major research funding, publish in highly respected journals, earn professorship roles, and launch their own labs at major oncology centers.

    The next grant cycle will open in Spring 2025. For more information or to join the HBF mailing list visit hopperbelmont.org.

    The HBF Inspiration Award is designed to be a launch pad for bright, innovative researchers to gain early-stage financial support for concepts that can change the paradigm of cancer research.

    About the Hopper-Belmont Foundation:
    Hopper-Belmont Foundation (HBF) is a non-profit, 501(c)(3) focused on identifying, motivating, and supporting exceptional early-career research talent, who are pursuing innovative approaches in solving health and wellness challenges. Founded in 2019 by non-profit research and patient advocacy foundation leaders, the HBF created the Inspiration Award as a core initiative of the Foundation. The award targets senior post-doctoral or clinical fellow (MD, PhD, MD/PHD) or primary investigators in the first three years of their initial faculty appointment, or clinical fellows in the first three years, or post-doctoral faculty in the first three years of tenure. HBF welcomes individuals and families to join their mission and help annually recognize amazing talent that can accelerate the road to cures. Tax deductible donations can be made directly at www.hopperbelmont.org/donate-now (100% of donations go directly to support research)

    GET IN TOUCH
    Greg Walsh
    Hopper-Belmont Foundation
    2032926280
    https://hopperbelmont.org/

    You can see the original version and more on PRLeap here: http://www.prleap.com/pr/300842/emerging-scientists-awarded-hopper-belmont-foundation-grants-to-fund-critical-pancreatic-and-ovarian-cancer-research

    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.


     

    IntelligentValue Home
    Close Window

    DISCLAIMER

    All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

    Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.